Position in MEDP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$91,458,074
+$3,692,788 QoQ
Shares Held
172,696
-5.5% QoQ
Ownership
0.619%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#38
of 691 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 94%
Shared 6%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GW&K Investment Management, LLC holds $306,980,755 across 16 Diagnostics & Research names. MEDP ranks #1 (29.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MEDP |
Medpace Holdings, Inc.
This page
|
172,696 | $91,458,074 | |
| 2 | VCYT |
Veracyte, Inc.
|
1,416,543 | $83,193,570 | |
| 3 | NTRA |
Natera, Inc.
|
231,308 | $62,788,555 | |
| 4 | NEO |
Neogenomics Inc
|
2,129,421 | $31,068,251 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
90,608 | $20,548,988 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
31,463 | $15,774,289 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
3,509 | $1,847,277 | |
| 8 | DHR |
Danaher Corp /De/
|
685 | $130,478 |
All Filings in MEDP
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $91,458,074 | 172,696 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $87,765,286 | 182,772 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $87,728,605 | 156,198 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $101,937,875 | 198,261 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $81,510,383 | 259,703 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $82,496,644 | 270,756 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $91,516,075 | 275,460 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $47,426,637 | 142,081 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $70,642,982 | 171,526 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $69,805,191 | 172,721 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $67,549,402 | 220,368 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $56,369,558 | 232,807 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $60,226,710 | 250,767 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $47,658,638 | 253,436 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $53,701,495 | 252,820 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $40,053,517 | 254,842 | Shares | Other | 2022-11-09 | |
| 2022-06-30 | $52,148,020 | 348,420 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $54,008,583 | 330,146 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $72,902,652 | 334,969 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $74,504,960 | 393,623 | Shares | Other | 2021-11-10 | |
| 2021-06-30 | $69,801,172 | 395,183 | Shares | Other | 2021-08-10 | |
| 2021-03-31 | $57,519,702 | 350,623 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $43,965,345 | 315,843 | Shares | Sole | 2021-02-05 | |
| No filing history on record for this holder in this stock. | ||||||